首页> 外国专利> CATECHOLAMINE CONCENTRATIONS IN A BLOOD SAMPLE AND ARTERIAL HYPERTENSION STATUS IN A SUBJECT FOR A DIFFERENTIAL DIAGNOSIS OF NEURODEGENERATIVE DISEASES INCLUDING ALZHEIMER'S DISEASE

CATECHOLAMINE CONCENTRATIONS IN A BLOOD SAMPLE AND ARTERIAL HYPERTENSION STATUS IN A SUBJECT FOR A DIFFERENTIAL DIAGNOSIS OF NEURODEGENERATIVE DISEASES INCLUDING ALZHEIMER'S DISEASE

机译:在血液样品中的儿茶酚胺浓度和动脉高压状态在鉴别诊断患有阿尔茨海默病的神经变性疾病的鉴别诊断

摘要

The invention has for object an in vitro method for performing a differential diagnosis of neurodegenerative diseases selected from early stage of Alzheimer's disease, advanced stage of Alzheimer's disease, mental depression, dementia with Lewy bodies, frontotemporal dementia, and/or vascular dementia; said method being performed in a subject presenting signs of dementia and comprising the steps of (a) determining at least five criteria of said subject, said at least five criteria comprising the age of said subject, a score of said subject to a questionnaire adapted for screening cognitive function, a dopamine, adrenaline and noradrenaline concentration in a blood sample of said subject, (b) comparing said noradrenaline concentration to a predetermined threshold, (c) calculating one global note in relation with each neurodegenerative disease and (d) determining whether said subject suffers from one or more neurodegenerative diseases.
机译:本发明具有对异性诊断从阿尔茨海默病,阿尔茨海默病,精神抑郁症,痴呆症,具有石油体,巨态痴呆和/或血管痴呆症中选择的神经变性疾病的差异诊断的体外诊断 所述方法在呈现痴呆症的迹象中,包括确定所述受试者的至少五个标准的(a)的步骤,所述包括所述受试者的年龄的至少五个标准,所述对调查问卷的评分 在所述受试者的血液样品中筛选认知功能,多巴胺,肾上腺素和去甲肾上腺素浓度,将所述去甲肾上腺素浓度与预定阈值进行比较,(c)与每个神经变性疾病和(d)确定一个全球注释确定是否 所述受试者患有一种或多种神经变性疾病。

著录项

  • 公开/公告号EP3959522A1

    专利类型

  • 公开/公告日2022-03-02

    原文格式PDF

  • 申请/专利权人 SAS ALZOHIS;

    申请/专利号EP20200718678

  • 申请日2020-04-17

  • 分类号G01N33/68;G01N33/94;

  • 国家 EP

  • 入库时间 2022-08-24 23:41:41

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号